⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMEA News
Biomea Fusion, Inc. Common Stock
Form 8-K
sec.gov
BMEA
Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist
globenewswire.com
BMEA
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
globenewswire.com
BMEA
Biomea Fusion Announces Termination of Proposed Public Offering of Securities
globenewswire.com
BMEA
Biomea Fusion Announces Proposed Public Offering of Securities
globenewswire.com
BMEA
Form 8-K
sec.gov
BMEA
Biomea Fusion to Participate in Upcoming Investor Conferences
globenewswire.com
BMEA
Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
globenewswire.com
BMEA
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
globenewswire.com
BMEA
Form 8-K
sec.gov
BMEA